Literature DB >> 27531875

Clinical and histopathological staging in oral squamous cell carcinoma - Comparison of the prognostic significance.

Matthias Kreppel1, Parvin Nazarli2, Andrea Grandoch2, Ali-Farid Safi2, Matthias Zirk2, Hans-Joachim Nickenig2, Martin Scheer3, Daniel Rothamel2, Martin Hellmich4, Joachim E Zöller2.   

Abstract

BACKGROUND: In oral cancer the prognostic significance of clinical staging (cTNM) is regarded inferior to histopathologic staging (pTNM) after surgery. This is mainly due to the point that the quality of the cTNM strongly depends on the clinical and radiological examination techniques applied and the physician's experience. The aim of this study was to evaluate the prognostic quality of cTNM and pTNM in a single center cohort.
METHODS: This retrospective study included 392 patients with treatment-naive oral squamous cell carcinoma (OSCC). All patients received primary surgery including a neck dissection. According to tumor stage and histopathologic risk factors patients received adjuvant radiotherapy (RT) or radiochemotherapy (RCT). Prognostic factors were identified in univariate analysis by using the log rank test and in multivariate analysis through Cox regression.
RESULTS: Clinical and histopathologic staging showed concordance in 62% for the primary tumor and 59% for cN- and pN-classification. In 58% of the cases of discordance the primary tumor was overstaged. In case of discordance of metastatic spread to the cervical lymph nodes, lymph node involvement showed overstaging in 78%. In univariate analysis cT-, cN-, cT- and pT-classification had a significant impact (p<0.05) on overall survival (OS). In multivariate analysis only pT- and pN-classification had a significant impact on OS.
CONCLUSION: Despite advances and modern radiologic techniques, pTNM has a higher prognostic quality than cTNM. Discordance between clinical and histopathologic staging was observed in up to 40%. When discordance was observed overstaging for clinical T-stage and clinical N-stage was more likely than understaging.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Oral squamous cell carcinoma; Prognosis; Staging; cTNM; pTNM

Mesh:

Year:  2016        PMID: 27531875     DOI: 10.1016/j.oraloncology.2016.07.004

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  9 in total

1.  Lymph node density as a prognostic predictor in patients with betel nut-related oral squamous cell carcinoma.

Authors:  Wei-Chin Chang; Chun-Shu Lin; Cheng-Yu Yang; Chih-Kung Lin; Yuan-Wu Chen
Journal:  Clin Oral Investig       Date:  2017-10-17       Impact factor: 3.573

2.  Effects of continuity of care on the postradiotherapy survival of working-age patients with oral cavity cancer: A nationwide population-based cohort study in Taiwan.

Authors:  Tsu Jen Kuo; Pei Chen Wu; Pei Ling Tang; Chun-Hao Yin; Chi Hsiang Chu; Yao-Min Hung
Journal:  PLoS One       Date:  2019-12-16       Impact factor: 3.240

3.  Suppression of G6PD induces the expression and bisecting GlcNAc-branched N-glycosylation of E-Cadherin to block epithelial-mesenchymal transition and lymphatic metastasis.

Authors:  Lin Wang; Chuanbin Guo; Yifei Wang; Qingxiang Li; Lixuan Niu; Le Xu; Yuxing Guo
Journal:  Br J Cancer       Date:  2020-07-28       Impact factor: 7.640

4.  Prognostic Role of Combined EGFR and Tumor-Infiltrating Lymphocytes in Oral Squamous Cell Carcinoma.

Authors:  Wattawan Wongpattaraworakul; Katherine N Gibson-Corley; Allen Choi; Marisa R Buchakjian; Emily A Lanzel; Anand Rajan Kd; Andrean L Simons
Journal:  Front Oncol       Date:  2022-07-25       Impact factor: 5.738

5.  Evaluation of the Cellular Dissociation Grading, Based on Tumor Budding and Cell Nest Size, in Squamous Cell Carcinoma of the Penis.

Authors:  Hayel Derani; Anne-Sophie Becker; Oliver Hakenberg; Andreas Erbersdobler
Journal:  Cancers (Basel)       Date:  2022-10-09       Impact factor: 6.575

6.  A novel prognostic index for oral squamous cell carcinoma patients with surgically treated.

Authors:  Fa Chen; Yujie Cao; Jiangfeng Huang; Lingjun Yan; Lisong Lin; Fengqiong Liu; Fangping Liu; Junfeng Wu; Yu Qiu; Lin Cai; Baochang He
Journal:  Oncotarget       Date:  2017-01-26

7.  Effects of income and residential area on survival of patients with head and neck cancers following radiotherapy: working age individuals in Taiwan.

Authors:  Yu Cheng Lai; Pei Ling Tang; Chi Hsiang Chu; Tsu Jen Kuo
Journal:  PeerJ       Date:  2018-09-17       Impact factor: 2.984

8.  Comparative Analysis of Clinical and Pathological Lymph Node Staging Data in Head and Neck Squamous Cell Carcinoma Patients Treated at the General Hospital Vienna.

Authors:  Christina Eder-Czembirek; Birgit Erlacher; Dietmar Thurnher; Boban M Erovic; Edgar Selzer; Michael Formanek
Journal:  Radiol Oncol       Date:  2018-05-11       Impact factor: 4.214

9.  Lymph node ratio as a predictor for outcome in oral squamous cell carcinoma: a multicenter population-based cohort study.

Authors:  Steffen Spoerl; Michael Gerken; Andreas Mamilos; René Fischer; Stefanie Wolf; Felix Nieberle; Christoph Klingelhöffer; Johannes K Meier; Silvia Spoerl; Tobias Ettl; Torsten E Reichert; Gerrit Spanier
Journal:  Clin Oral Investig       Date:  2020-08-04       Impact factor: 3.573

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.